Literature DB >> 25247846

Screening for alcohol and substance use for older people in geriatric hospital and community health settings.

Brian Draper1, Nicole Ridley2, Carly Johnco3, Adrienne Withall4, Welkee Sim5, Matilda Freeman6, Erika Contini7, Nicholas Lintzeris8.   

Abstract

BACKGROUND: We aimed to determine the rates of alcohol and substance use in geriatric hospital and community health settings, and to evaluate the performance of screening instruments.
METHOD: A two-phase cross-sectional study was undertaken in geriatric and aged care psychiatry wards and associated community services of a teaching hospital. Participants were screened with the Brief Alcohol Use Disorders Identification Test (AUDIT-C) and the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for other substances; Geriatric Depression Scale-15 for mood; the Connor-Davidson Resilience Scale; and the Subjective Quality of Life scale. Medical conditions were established. Screen positives for risky substance use continued with the full AUDIT, full ASSIST, CAGE, Addenbrooke's Cognitive Examination-Revised, and the Functional Activities Questionnaire. Medical records were reviewed after three months to ascertain recognition and management of substance use.
RESULTS: Of 210 participants aged 60+ (mean age 81.9, 63.3% female) without dementia or delirium and Mini Mental State Examination score ≥24, 41 (19.5%) were screen positive - 36 (17.1%) for alcohol, seven for non-medical benzodiazepine use (3.3%) (four alcohol and benzodiazepine) and two for non-medical opioid use (0.95%). Screen positives differed from screen negatives on few demographic or health measures. On the ASSIST, 26 (12.4%) were rated as medium/high risk. The AUDIT-C with cut-point of ≥5 was the optimal measure for detecting risky alcohol use.
CONCLUSIONS: Many patients in geriatric health services have risky alcohol or substance use, but few clinical features distinguish them from other patients. Routine screening of alcohol and substance use is recommended.

Entities:  

Mesh:

Year:  2014        PMID: 25247846     DOI: 10.1017/S1041610214002014

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  7 in total

1.  Lifetime alcohol use and cognitive performance in older adults.

Authors:  Raj K Kalapatapu; Maria I Ventura; Deborah E Barnes
Journal:  J Addict Dis       Date:  2016-10-08

2.  Beck Depression Inventory-II: Factor Analyses with Three Groups of Midlife Women of African Descent in the Midwest, the South, and the U.S. Virgin Islands.

Authors:  Faye A Gary; Hossein Yarandi; Edris Evans; Carolyn Still; Prince Mickels; Mona Hassan; Doris Campbell; Ruzica Conic
Journal:  Issues Ment Health Nurs       Date:  2017-12-01       Impact factor: 1.835

Review 3.  Is there room for resilience? A scoping review and critique of substance use literature and its utilization of the concept of resilience.

Authors:  Katherine Rudzinski; Peggy McDonough; Rosemary Gartner; Carol Strike
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-09-15

4.  Elevated alcohol consumption among geriatric psychiatric in-patients.

Authors:  Anne-Sofie Helvik; Knut Engedal; Aud Johannessen
Journal:  Nordisk Alkohol Nark       Date:  2020-07-14

5.  Canadian Guidelines on Opioid Use Disorder Among Older Adults.

Authors:  Launette M Rieb; Zainab Samaan; Andrea D Furlan; Kiran Rabheru; Sid Feldman; Lillian Hung; George Budd; Douglas Coleman
Journal:  Can Geriatr J       Date:  2020-03-30

6.  Alcohol and prescribed psychotropic drug use among patients admitted to a department of old-age psychiatry in Norway.

Authors:  Aud Johannesen; Knut Engedal; Marianne Larsen; Elin Lillehovde; Line Tegner Stelander; Anne-Sofie Helvik
Journal:  Nordisk Alkohol Nark       Date:  2017-03-17

7.  Assessment of alcohol and psychotropic drug use among old-age psychiatric patients in Norway: Experiences of health professionals.

Authors:  Aud Johannessen; Knut Engedal; Anne-Sofie Helvik
Journal:  Nordisk Alkohol Nark       Date:  2017-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.